These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34728309)

  • 1. Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries.
    Zhao S; Huang L; Basu P; Domingo EJ; Supakarapongkul W; Ling WY; Ocviyanti D; Rezhake R; Qiao Y; Tay EH; Zhao F
    Cancer Lett; 2022 Jan; 525():22-32. PubMed ID: 34728309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review.
    Setiawan D; Oktora MP; Hutubessy R; Riewpaiboon A; Postma MJ
    Expert Rev Vaccines; 2017 Sep; 16(9):933-943. PubMed ID: 28730914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A consensus plan for action to improve access to cancer care in the association of Southeast Asian Nations (ASEAN) region.
    Woodward M
    Asian Pac J Cancer Prev; 2014; 15(19):8521-6. PubMed ID: 25339057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cancer in low- and middle-income countries.
    Sankaranarayanan R
    Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of HPV testing in Latin America.
    Jeronimo J; Holme F; Slavkovsky R; Camel C
    J Clin Virol; 2016 Mar; 76 Suppl 1():S69-S73. PubMed ID: 26699418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
    Pimple SA; Mishra GA
    Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support.
    Keane A; Ng CW; Simms KT; Nguyen D; Woo YL; Saville M; Canfell K
    Int J Cancer; 2021 Dec; 149(12):1997-2009. PubMed ID: 34363620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya.
    Huchko MJ; Kahn JG; Smith JS; Hiatt RA; Cohen CR; Bukusi E
    BMC Cancer; 2017 Dec; 17(1):826. PubMed ID: 29207966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
    Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
    Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV testing as a screen for cervical cancer.
    Goodman A
    BMJ; 2015 Jun; 350():h2372. PubMed ID: 26126623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness and Beliefs About Cervical Cancer, the HPV Vaccine, and Cervical Cancer Screening Among Ghanaian Women with Diverse Education Levels.
    Williams MS; Kenu E; Adanu A; Yalley RA; Lawoe NK; Dotse AS; Adu RF; Fontaine K
    J Cancer Educ; 2019 Oct; 34(5):897-903. PubMed ID: 29974412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
    Belinson SE; Belinson JL
    Mol Diagn Ther; 2010 Aug; 14(4):215-22. PubMed ID: 20799763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
    Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
    Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
    Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
    Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
    BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.